The Asia Pacific Surgical Sealants and Adhesives Market size was valued at USD 432.61 million in 2022 and is expected to grow at a CAGR of 9.8 %, to reach USD 690.42 million by 2027 from 2022 to 2027.
The growing number of surgical procedures performed in the region, as well as technological advancements, rise in the geriatric population and increased awareness of the potential benefits of surgical sealants in surgical operations are expected to propel the Asia pacific surgical sealants and adhesives market forward. In the forecast period, better healthcare systems in this nation would boost numerous prospects, leading to the rise of the surgical sealants and adhesives market. Minimally invasive surgery is an alternative since it only requires a minor incision to complete the process, which avoids the dangers of bleeding and air leak.
The rising prevalence and incidence rates of various conditions such as obesity and CVDs, as well as the rising incidence of trauma and the rise in the number of accidents and sports-related injuries, have all contributed to an increase in surgical procedures conducted around the region. In addition, recent advancements have resulted in the development of biocompatible sealants, which have reduced the risks of invasive surgery. Wound infection, severe bleeding, and tissue damage are all common complications of surgical operations. Furthermore, diabetic patients must exercise special caution because the risk of problems before and after surgery is much higher in their case.
Surgical sealants and adhesives market growth is expected to be restrained by the high cost of clinical data for new product launches, rising healthcare expenditures, and a lack of reimbursements during the forecast period. The market will face a substantial challenge in the development of innovative biomaterials. The rate of market growth will be slowed by fluctuations in raw material prices. The market's growth rate will also be slowed by the availability of alternatives and scarcity of skilled professionals will hinder market expansion.
This research report on the Asia Pacific Surgical Sealants and Adhesives Market has been segmented and sub-segmented into the following categories.
By Product:
By Indication:
By Application:
By Country:
Asia-Pacific is expected to grow at the fastest rate during the forecast period, owing to increased investments by major players in these regions, rising health awareness, rising per capita income, increasing medical tourism, the presence of less stringent regulations, and the growing demand for quality healthcare. The main cause of the market's rapid expansion is an increase in the prevalence of cardiovascular disorders.
Rising industrialization, combined with an increase in the number of accidents and sports-related injuries, would have a direct and beneficial impact on the market's growth rate. Growth and expansion of the healthcare industry, particularly in emerging nations such as India and China, combined with an increase in demand for minimally invasive surgical treatments, would pave the way for market expansion.
Because of the ongoing transformation of healthcare delivery systems towards advanced value-based healthcare practices that produce a sustainable health system, Asia Pacific is likely to see considerable market expansion. This would enable consumers to obtain cheaper and better services at a lower cost, as well as promote the implementation of novel surgical and other healthcare treatments.
Top Companies dominating the Asia Pacific Surgical Sealants and Adhesives Market Profiled in the Report are CryoLife, Inc, Johnson & Johnson, Ethicon, Inc., Baxter International, Inc, and C.R. Bard, Inc, Cohera Medical, Inc. Ocular Therapuetix, Inc, Vivostat A/S and Sealants Ltd, Medtronic plc, Sanofi Group, B. Braun Melsungen AG
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Natural/Biological Sealants and Adhesives
5.1.2.1 Natural/Biological Sealants and Adhesives, By Type
5.1.2.1.1 Polypeptide/Protein-Based Sealants and Adhesives
5.1.2.1.1.1 Fibrin Based
5.1.2.1.1.2 Collagen Based
5.1.2.1.1.3 Gelatin Based
5.1.2.1.1.4 Albumin Based
5.1.2.1.2 Polysaccharide Based Sealants and Adhesives
5.1.2.1.2.1 Chitosan Based
5.1.2.1.2.2 Other Polysaccharide Based
5.1.2.2 Natural/Biological Sealants and Adhesives, By Origin
5.1.2.2.1 Human Blood-Based
5.1.2.2.2 Animal-Based
5.1.3 Synthetic and Semisynthetic Sealants and Adhesives
5.1.3.1 Cyanoacrylates
5.1.3.2 Polyethylene Glycol Based Hydrogel
5.1.3.3 Urethane-Based Adhesives
5.1.3.4 Other Synthetic Sealants and Adhesives
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Indication
5.2.1 Introduction
5.2.2 Surgical Hemostasis
5.2.3 Tissue Sealing
5.2.4 Tissue Engineering
5.2.5 Y-o-Y Growth Analysis, By Indication
5.2.6 Market Attractiveness Analysis, By Indication
5.2.7 Market Share Analysis, By Indication
5.3 Application
5.3.1 Introduction
5.3.2 Central Nervous System (CNS) Surgeries
5.3.3 General Surgeries
5.3.4 Cardiovascular Surgeries
5.3.5 Orthopedic Surgeries
5.3.6 Cosmetic Surgeries
5.3.7 Ophthalmic Surgeries
5.3.8 Urological Surgeries
5.3.9 Pulmonary Surgeries
5.3.10 Other Applications
5.3.11 Y-o-Y Growth Analysis, By Application
5.3.12 Market Attractiveness Analysis, By Application
5.3.13 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Indication
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Indication
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Indication
6.1.5.4 By Application
6.2 India
6.3 China
6.4 Japan
6.5 Australia
6.6 South Korea
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Johnson & Johnson (Ethicon, Inc.; U.S.)
8.3 CryoLife, Inc. (U.S.)
8.4 C. R. Bard
8.5 Aastrom Biosciences
8.6 Medtronic plc (U.S.)
8.7 Sanofi Group (France)
8.8 B. Braun Melsungen AG (Germany)
8.9 Cohera Medical
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
